Stock LAB STANDARD BIOTOOLS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Standard BioTools Inc.

Equities

LAB

US34385P1084

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
2.44 USD +3.39% Intraday chart for Standard BioTools Inc. -3.17% +10.41%
04-25 Sector Update: Health Care Stocks Decline Late Afternoon MT
04-25 Sector Update: Health Care MT

Evolution of the average Target Price on Standard BioTools Inc.

Price target over the last 5 years

History of analyst recommendation changes

3b5d78cb82da9b1.rkZZtwLSzCAmGvpkRMZvstKHPMIZDSInfPcLgKIcVuE.1hUh1Ea3-1BoS80SIYwG1ePAbZMgT2F4LJJUxtgrZtTEJAnBS7C8bUVblQ~7494df56144e2ccf97e664b11447ee7d

Analyst Recommendations on Standard BioTools Inc.

TD Cowen Starts Standard BioTools With Buy Rating, $3.50 Price Target MT
Jefferies Initiates Coverage on Standard BioTools With Buy Rating, $3.25 Price Target MT
KeyBanc Initiates Standard BioTools at Overweight With $4 Price Target, Sees 'Attractively Valued Way to Invest' in Life Sciences Technology MT
BTIG Adjusts Fluidigm's Price Target to $10 From $12, Reiterates Buy Rating MT
FLUIDIGM : UBS Adjusts Fluidigm's Price Target to $9 From $10, Reiterates Buy Rating MT
FLUIDIGM : UBS Adjusts Fluidigm's Price Target to $10 From $15, Citing Lower Revenue Forecasts for COVID Testing Business; Buy Rating Kept MT
FLUIDIGM : Piper Sandler Adjusts Fluidigm's Price Target to $15 from $12, Maintains Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.44 USD
Average target price
3.583 USD
Spread / Average Target
+46.86%
High Price Target
4 USD
Spread / Highest target
+63.93%
Low Price Target
3.25 USD
Spread / Lowest Target
+33.20%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Standard BioTools Inc.

TD Cowen
Jefferies & Co.
KeyBanc Capital Markets
BTIG
UBS

Ratings for Standard BioTools Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. LAB Stock
  4. Consensus Standard BioTools Inc.